南京聚隆(300644.SZ):擬投資建設聚隆科技年產4萬噸特種材料生產項目
格隆匯6月13日丨南京聚隆(300644.SZ)公佈,為推進公司發展戰略,擴大規模,滿足市場需求,降本增效,提升智能化製造水平,公司擬與南京江北新區智能製造產業發展管理辦公室簽訂《項目合作協議》。公司將在南京江北新區新錦湖路6號租賃5800㎡廠房,項目總投資1.3億元,投資建設“聚隆科技年產4萬噸特種材料生產項目”。該項目將新建特種材料生產線及立體庫,主要生產阻燃類產品,旨在進一步優化公司產品結構,增強市場競爭力,為公司的可持續發展奠定堅實基礎。項目投資進度視市場發展情勢,分期投資及實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.